HLK Biotech Holding Group, Inc. (AMHD)
HLK Biotech Holding Group, Inc. operates primarily through its various subsidiaries, focusing on the production and distribution of biodiesel. In addition to its energy sector activities, the company also engages in the acquisition of real estate assets. The firm was formerly recognized as Amelot Holdings, Inc., but it officially rebranded to HLK Biotech Holding Group, Inc. in February 2018. The company's principal office is located in Norfolk, Virginia.
Sector: Drug Manufacturers - Specialty & Generic
Industry: Drug Manufacturers - Specialty & Generic
HLK Biotech Holding Group, Inc.
OTC:AMHDHealthcare · Drug Manufacturers - Specialty & Generic
$0.0003
CLOSED · Nov 12Prev close$0.0002Close$0.0003
Mkt Cap$1K
EV-
Float-
O/S4.63M
VOL1K sh
$ Vol$0
RVOL1.00×
Inst Own-
Net Cash/Sh-
Dilution
MCap$1KFloat-O/S4.63M
Dilution
Financials Summary
No financial data available.
Debt & Equity
No debt & equity data available.
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:1,000Reverse splitFeb 23, 20181,000 shares → 1
Balance Sheet Details
No balance sheet details available.
Income Statement
No income statement data available.
Balance Sheet
No balance sheet data available.
Cash Flow Statement
No cash flow data available.